Raymond James Increases Solazyme Price Target to $12.50 (SZYM)

Share on StockTwits

Solazyme (NASDAQ: SZYM) had its price target increased by Raymond James from $10.50 to $12.50 in a research report sent to investors on Monday morning, Stock Ratings Network.com reports. The firm currently has an outperform rating on the stock.

A number of other analysts have also recently weighed in on SZYM. Analysts at Robert W. Baird raised their price target on shares of Solazyme from $10.00 to $12.00 in a research note to investors on Friday, May 10th. They now have an outperform rating on the stock. Analysts at Morgan Stanley initiated coverage on shares of Solazyme in a research note to investors on Friday, April 19th. They set an overweight rating on the stock.

Nine equities research analysts have rated the stock with a buy rating, The stock presently has a consensus rating of Buy and an average price target of $12.63.

Shares of Solazyme (NASDAQ: SZYM) opened at 11.91 on Monday. Solazyme has a 52 week low of $6.45 and a 52 week high of $14.34. The stock’s 50-day moving average is currently $8.1. The company’s market cap is $736.4 million.

Solazyme, Inc. (NASDAQ: SZYM) makes oil.

Latest News

Coolest Cooler Kicks Up $13 Million
Coolest Cooler Kicks Up $13 Million
Fiat-Chrysler IPO Coming in October
Fiat-Chrysler IPO Coming in October
FBI Investigating Hack Attack at JPMorgan
FBI Investigating Hack Attack at JPMorgan
Tiffany Sees Strong Sales Growth During Second Quarter
Tiffany Sees Strong Sales Growth During Second Quarter
HubSpot Planning an IPO of $100 Million
HubSpot Planning an IPO of $100 Million
Roche Acquires InterMune
Roche Acquires InterMune


Leave a Reply

 
 
© 2006-2014 Ticker Report. Google+.